Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette Molinaro

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Archives of Pathology & Laboratory Medicine|October 7, 2008
Comparison of quantitative immunofluorescence with conventional methods for HER2/neu testing with respect to response to trastuzumab therapy in metastatic breast cancerJennifer M Giltnane, Annette Molinaro, Huan Cheng, et al.
Cancer|April 28, 2011
A phase 2 trial of dasatinib in advanced melanomaHarriet M Kluger, Arkadiuz Z Dudek, Carrie McCann, et al.
Journal of the National Cancer Institute|November 20, 2003
Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomyKarla Kerlikowske, Annette Molinaro, Imok Cha, et al.
Journal of Neurological Surgery. Part B, Skull Base|March 22, 2017
Cost-Effectiveness Analysis of Surgical versus Medical Treatment of ProlactinomasCorinna C Zygourakis, Brandon S Imber, Rebecca Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2011
Plasma markers for identifying patients with metastatic melanomaHarriet M Kluger, Kathleen Hoyt, Antonella Bacchiocchi, et al.
Journal of Neuro-Oncology|September 6, 2014
Pure germinomas of the central nervous system: treatment strategies and outcomesAdam Schoenfeld, Daphne A Haas-Kogan, Annette Molinaro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2007
Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American Society of Clinical Oncology/College of American Pathologists guidelines: tumor heterogeneity in breast cancer and its implications for tissue microarray based assessment of outcomeChristopher B Moeder, Jennifer M Giltnane, Malini Harigopal, et al.
Journal of Neurosurgery. Pediatrics|March 25, 2022
Socioeconomic factors associated with pediatric moyamoya disease hospitalizations: a nationwide cross-sectional studyKunal P Raygor, Ryan R L Phelps, Caleb Rutledge, et al.
Cancer|March 29, 2002
The APC/beta-catenin pathway in ulcerative colitis-related colorectal carcinomas: a mutational analysisDaniela E Aust, Jonathan P Terdiman, Robert F Willenbucher, et al.
Neurospine|October 15, 2019
Preoperative Narcotic Use, Impaired Ambulation Status, and Increased Intraoperative Blood Loss Are Independent Risk Factors for Complications Following Posterior Cervical Laminectomy and Fusion SurgeryRyan K Badiee, Andrew K Chan, Joshua Rivera, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Archives of Pathology & Laboratory Medicine|October 7, 2008
Comparison of quantitative immunofluorescence with conventional methods for HER2/neu testing with respect to response to trastuzumab therapy in metastatic breast cancerJennifer M Giltnane, Annette Molinaro, Huan Cheng, et al.
Cancer|April 28, 2011
A phase 2 trial of dasatinib in advanced melanomaHarriet M Kluger, Arkadiuz Z Dudek, Carrie McCann, et al.
Journal of the National Cancer Institute|November 20, 2003
Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomyKarla Kerlikowske, Annette Molinaro, Imok Cha, et al.
Journal of Neurological Surgery. Part B, Skull Base|March 22, 2017
Cost-Effectiveness Analysis of Surgical versus Medical Treatment of ProlactinomasCorinna C Zygourakis, Brandon S Imber, Rebecca Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2011
Plasma markers for identifying patients with metastatic melanomaHarriet M Kluger, Kathleen Hoyt, Antonella Bacchiocchi, et al.
Journal of Neuro-Oncology|September 6, 2014
Pure germinomas of the central nervous system: treatment strategies and outcomesAdam Schoenfeld, Daphne A Haas-Kogan, Annette Molinaro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2007
Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American Society of Clinical Oncology/College of American Pathologists guidelines: tumor heterogeneity in breast cancer and its implications for tissue microarray based assessment of outcomeChristopher B Moeder, Jennifer M Giltnane, Malini Harigopal, et al.
Journal of Neurosurgery. Pediatrics|March 25, 2022
Socioeconomic factors associated with pediatric moyamoya disease hospitalizations: a nationwide cross-sectional studyKunal P Raygor, Ryan R L Phelps, Caleb Rutledge, et al.
Cancer|March 29, 2002
The APC/beta-catenin pathway in ulcerative colitis-related colorectal carcinomas: a mutational analysisDaniela E Aust, Jonathan P Terdiman, Robert F Willenbucher, et al.
Neurospine|October 15, 2019
Preoperative Narcotic Use, Impaired Ambulation Status, and Increased Intraoperative Blood Loss Are Independent Risk Factors for Complications Following Posterior Cervical Laminectomy and Fusion SurgeryRyan K Badiee, Andrew K Chan, Joshua Rivera, et al.
Pageof 4